591 related articles for article (PubMed ID: 11501722)
1. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
[TBL] [Abstract][Full Text] [Related]
3. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis.
Lock G; Pfeifer M; Straub RH; Zeuner M; Lang B; Schölmerich J; Holstege A
Am J Gastroenterol; 1998 Mar; 93(3):341-5. PubMed ID: 9517636
[TBL] [Abstract][Full Text] [Related]
4. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
[TBL] [Abstract][Full Text] [Related]
5. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
6. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.
Marie I; Levesque H; Ducrotté P; Denis P; Benichou J; Hellot MF; Cailleux N; Le Loët X; Joly P; Lauret P; Courtois H
Arthritis Rheum; 1998 Oct; 41(10):1874-83. PubMed ID: 9778230
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
8. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
[TBL] [Abstract][Full Text] [Related]
9. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy.
Marie I; Ducrotte P; Denis P; Hellot MF; Levesque H
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1593-601. PubMed ID: 17206947
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
Christmann RB; Wells AU; Capelozzi VL; Silver RM
Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
[TBL] [Abstract][Full Text] [Related]
11. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
[TBL] [Abstract][Full Text] [Related]
12. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
15. Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up.
Marie I; Ducrotté P; Denis P; Hellot MF; Levesque H
Rheumatology (Oxford); 2007 Jan; 46(1):150-3. PubMed ID: 16782730
[TBL] [Abstract][Full Text] [Related]
16. Gastric involvement in systemic sclerosis: a prospective study.
Marie I; Levesque H; Ducrotté P; Denis P; Hellot MF; Benichou J; Cailleux N; Courtois H
Am J Gastroenterol; 2001 Jan; 96(1):77-83. PubMed ID: 11197291
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
Furuya Y; Kuwana M
J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
[TBL] [Abstract][Full Text] [Related]
20. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]